Interview with Sabri Faisal Sabri

Managing Director 
DaVita - KSA

Sabri Sabri leads DaVita Saudi Arabia business responsible for providing kidney services for more than 3,000 patients with 25 clinics and 950+ teammates. DaVita Inc. is a Fortune 500 health care company based in Denver, Colorado, with a market cap of USD $10.88 billion. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years Sabri has a bachelor degree in Accounting from the University of Toledo and a Master of Business Administration from University of Phoenix.

He joined DaVita in 2014 as the Chief Financial Officer he became National Operations Director, and helped grow the Saudi Arabia operations from the beginning. He has more than 25 years of experience across different industries of which 15 years in Saudi Arabia market. He worked for AT&T in the U.S, Motorola and Microsoft in Saudi Arabia. He has extensive experience in building start-up / “green field” operations in the Kingdom.

 

Tell us about the organisation you lead and its role in the healthcare industry.

DaVita Inc., a Fortune 500® company, is one of the USA’s largest and most innovative healthcare providers, leveraging a passion for and commitment to clinical excellence to improve patients’ health and quality of life. As part of its growth, DaVita KSA was established in 2014 under the umbrella of the Ministry of Health to improve the quality of life for kidney patients across the Kingdom. 

We operate 25 centres across the Kingdom and serve more than 3,000 patients with kidney failure. With our global expertise and local deep understanding of the Saudi healthcare sector, DaVita is uniquely positioned to deliver 2030 Saudi Vision across kidney care services with a focus on innovative and preventive care with patient-centric and clinical excellence values at the core.

What are your thoughts on the healthcare industry in Saudi Arabia and its recent development?

The healthcare industry in the Kingdom has witnessed significant development over the years behind the drive of Vision 2030. The Ministry of Health has been investing heavily in kidney healthcare with an aim to improve access to kidney failure patients and transform it to be more efficient and sustainable. The healthcare industry in Saudi Arabia is continuously evolving, offering opportunities for foreign entities to contribute as well as collaborate to provide the highest quality healthcare services to its citizens

Please identify some key areas of growth and the role your organisation is playing in tapping into various opportunities and partnerships.

With DaVita and the Ministry of Health’s 10-year partnership, we have positively impacted thousands of lives across the Kingdom. The exceptional results and positive
impact can only be accomplished via a solid, long-term partner, one who consistently invests in the community and infrastructure to deliver clinical excellence. This strong foundation allowed us to innovate on core dialysis, where we utilised our 30 years of kidney care expertise in the US and around the world.

One example is our Home Hemodialysis service, where we have been able to reapply our best-in-class global practices, as what we have done in the US and Colombia and introduced this to the Saudi market. With our ongoing pursuit of clinical excellence, we are expanding our use of predictive AI-based decision support models such as our Command Center.

Another example is our unique focus on prevention care in collaboration with the MOH to screen citizens in the Kingdom to ensure a greater quality of life for all Saudis at risk of kidney disease.

Tell us about your portfolio, recent achievements, and goals for the next 12 months.

My name is Sabri Faisal Sabri, Managing Director for DaVita Saudi Arabia. I have been withDaVita since its inception in the Kingdom in 2014 serving the company in
different capacities. 

Our most recent achievements include the rollout of DaVita Kidney Care Pathway, which was announced last year at the Global Health Exhibition in Riyadh, and our Kidney Care programme where we have been able to reach more than 25,000 participants as part of pilots in Makkah and Madinah. In addition, we expanded our Home Haemodialysis programme. As we look ahead, we are focused on three main areas — kidney disease prevention, home dialysis, and the DaVita Experience for our patients, partners, and teammates.

What will you be showcasing at the Global Health Exhibition 2023 and what are you looking forward to most at the event?

Events like GHE provides us the opportunity to showcase DaVita KSA and the solid programmes that sets us apart from other kidney care providers. I encourage all of you to visit our stand and allow us to take you through a journey all the way from prevention care to ESKD, Home Hemodialysis, our secret ingredient which is the ‘Community First Company Second’ wall, as well as meeting our great team that lives our DaVita way in every aspect. We look forward to learning from the exceptional
pool of knowledge at the event and connecting with current and future partners.